• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:POLBF)

0.0425 UNCHANGED
Last Price Updated: 11:43 AM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about POLBF

< Previous 1 2 3 Next >
News headline image
Poolbeg-led Consortium Awarded EUR 2.3m Grant
November 15, 2022
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces AI Programme Yields Novel RSV Drug Targets
November 08, 2022
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces CEO Share Purchase
October 06, 2022
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces POLB 001 US Patent update
October 04, 2022
Via ACCESSWIRE
News headline image
Poolbeg Licence of Melioidosis Vaccine Candidate
September 21, 2022
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces HC Wainwright Global Investment Conference
September 12, 2022
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Appointment of Joint Broker
July 29, 2022
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces POLB001 Human Challenge Clinical Trial To Commence
July 20, 2022
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Appointment of Joint Broker
July 29, 2022
LONDON, UK / ACCESSWIRE / July 29, 2022 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) ('Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a unique capital light... 
From Poolbeg Pharma PLC
Via AccessWire
News headline image
Poolbeg Pharma PLC Announces POLB001 Human Challenge Clinical Trial To Commence
July 20, 2022
Major milestone reached as POLB 001 human challenge clinical trial ready to commence 
From Poolbeg Pharma PLC
Via AccessWire
News headline image
Poolbeg Pharma PLC Announces Project update for AI model of RSV data
June 27, 2022
OneThree Biotech completes build and optimisation of AI model for RSV data - results to come in H2 
From Poolbeg Pharma PLC
Via AccessWire
Topics Artificial Intelligence
News headline image
Poolbeg Pharma PLC Announces US Patents Granted for POLB 001 and POLB 002
May 26, 2022
Further Expansion of IP Portfolio Enhancing Protection of Poolbeg's Growing Pipeline 
From Poolbeg Pharma PLC
Via AccessWire
Topics Intellectual Property
News headline image
Poolbeg Pharma PLC - GMP Manufacturing Contract Signed
May 12, 2022
Update on POLB 001 Clinical Development GMP manufacturing contract signed ensuring ample supply of POLB 001 for clinical development and for use in investigating further potential disease indications... 
From Poolbeg Pharma PLC
Via AccessWire
News headline image
Poolbeg Pharma PLC Announces Result of AGM
April 04, 2022
LONDON, UK / ACCESSWIRE / April 4, 2022 / Poolbeg Pharma (AIM:POLB, OTCQB:POLBF, 'Poolbeg' or the 'Company') a clinical stage infectious disease pharmaceutical company with a unique capital light... 
From Poolbeg Pharma PLC
Via AccessWire
News headline image
Poolbeg Pharma PLC Announces POLB001 Update - Clinical Trial Agreement Signed
March 31, 2022
On track to commence LPS human challenge clinical trial in June 2022 LONDON, UK / ACCESSWIRE / March 31, 2022 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), ('Poolbeg' or the 'Company') announces that it... 
From Poolbeg Pharma PLC
Via AccessWire
News headline image
Poolbeg Pharma PLC Announces Commencement of Trading on US OTCQB Market
March 30, 2022
Poolbeg Pharma commences trading on OTCQB Market in the United States LONDON, UK / ACCESSWIRE / March 30, 2022 / Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical stage infectious... 
From Poolbeg Pharma PLC
Via AccessWire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap